Interventional Cardiology Solution Introduced Simultaneously in Opposite Parts of the World
Alphenix / Evolve Edition is a new imaging solution from Canon Medical Systems for interventional cardiology suites. It utilizes real-time Deep Learning technology to help clinicians reduce the X-ray dose and contrast media usage while maintaining high image quality. Its technologies, which are packaged as Evolve Technology, assist with daily interventional cardiology procedures, and elevate clinical confidence and procedural efficiency.
On August 4 to 6, in conjunction with the 31st Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT 2023) in Fukuoka, Japan, Canon conducted the release of the new X-ray angiography system.
Around the same time, Canon also actively conducted promotional activities in SOLACI (Sociedad Latino Americana de Cardiologia Intervencionista) for Alphenix / Evolve Edition in Brazil for customers in Central and South America.
SOLACI is the Latin American Society of Interventional Cardiology's largest cardiovascular medicine meeting in Central and South America. This meeting was held with the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), Brazil's largest cardiovascular medicine meeting, in Rio de Janeiro, Brazil, from August 2 to 4, 2023.
As part of the global launch events for Alphenix / Evolve Edition, Canon presented an exhibition booth at the conference and cohosted a lunch symposium to promote the system in Central and South America.
The symposium was held on the first day of SOLACI and tackled the topic: "Elevate the Interventional Cardiology Procedure with Artificial Intelligence." The session explored the clinical benefits of Canon's first, real-time AI processing technology, as incorporated in Alphenix / Evolve Edition.
Around the same time, Canon also actively conducted promotional activities in SOLACI (Sociedad Latino Americana de Cardiologia Intervencionista) for Alphenix / Evolve Edition in Brazil for customers in Central and South America.
SOLACI is the Latin American Society of Interventional Cardiology's largest cardiovascular medicine meeting in Central and South America. This meeting was held with the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), Brazil's largest cardiovascular medicine meeting, in Rio de Janeiro, Brazil, from August 2 to 4, 2023.
As part of the global launch events for Alphenix / Evolve Edition, Canon presented an exhibition booth at the conference and cohosted a lunch symposium to promote the system in Central and South America.
The symposium was held on the first day of SOLACI and tackled the topic: "Elevate the Interventional Cardiology Procedure with Artificial Intelligence." The session explored the clinical benefits of Canon's first, real-time AI processing technology, as incorporated in Alphenix / Evolve Edition.
Virtual demonstrations for customers visiting the booth
Virtual demonstrations for customers visiting the booth
Canon Medical Systems Brazil’s Team pictured in front of the booth
Canon Medical Systems Brazil’s Team pictured in front of the booth
Opening remarks by Dr. Ari Mandil (center), Chair of the event
Dr. Ari Mandil of Hospital Felício Rocho (one of the “World's Best Hospitals" according to the Newsweek Magazine) Chaired the event. He is a leading figure in Brazil's Cardiovascular Society and was the President of SBHCI 2022. Dr. Mandil moderated the symposium to encourage lively discussions about the clinical values of Canon latest technologies.
Opening remarks by Dr. Ari Mandil (center), Chair of the event
The first speaker was Dr. Marco Wainstein (Director of Cardiology at Hospital de Clinicas de Porto Alegre), and uses our systems in Brazil.
Dr. Wainstein delivered an educational lecture entitled: "The Importance of Advance Planning for Successful Transcatheter Aortic Valve Replacement (TAVR)." He discussed the importance of formulating preoperative and intraoperative plans for TAVR procedures following established guidelines.
Dr. Wainstein delivered an educational lecture entitled: "The Importance of Advance Planning for Successful Transcatheter Aortic Valve Replacement (TAVR)." He discussed the importance of formulating preoperative and intraoperative plans for TAVR procedures following established guidelines.
Cookies: We are sorry we can’t show you this video – as matter of your Cookies preferences. Accept here the Targeting Cookies to watch the video content.
Cookies: We are sorry we can’t show you this video – as matter of your Cookies preferences. Accept here the Targeting Cookies to watch the video content.
The second speaker was Dr. Masahiko Asami (Chief of Cardiology at Mitsui Memorial Hospital, Japan). Dr. Asami, a user of Alphenix, presented a lecture entitled: "The Potential of Canon's AI Technologies in Complex Cases.", which nicely complemented the lecture delivered by Dr. Wainstein. Dr. Asami gave an outline of Evolve Imaging. Utilizing Deep Learning technology in real-time provides cleaner and more defined images with less noise. Dr. Asami also described his high expectations for this technology.
Cookies: We are sorry we can’t show you this video – as matter of your Cookies preferences. Accept here the Targeting Cookies to watch the video content.
The third speaker was Dr. Sanjeeven Pasupati of Waikato Hospital, New Zealand, who is also a user of our systems.
Dr. Pasupati delivered his lecture online. He discussed the clinical usefulness of the AI-based Dynamic Device Stabilizer (DDS), a function of Alphenix for improving the visualization of coronary artery stents. He also reported his initial clinical assessment of Echo Fusion technology based on its use in Structural Heart Disease patients. Echo Fusion is one of the Evolve Technology, which automatically detects the echocardiography probe and fuses the fluoroscopic image without additional operator input.
Dr. Pasupati delivered his lecture online. He discussed the clinical usefulness of the AI-based Dynamic Device Stabilizer (DDS), a function of Alphenix for improving the visualization of coronary artery stents. He also reported his initial clinical assessment of Echo Fusion technology based on its use in Structural Heart Disease patients. Echo Fusion is one of the Evolve Technology, which automatically detects the echocardiography probe and fuses the fluoroscopic image without additional operator input.
Cookies: We are sorry we can’t show you this video – as matter of your Cookies preferences. Accept here the Targeting Cookies to watch the video content.
At this event, we invited international speakers to promote Alphenix / Evolve Edition and help transform the cardiovascular market in Central and South America. As a result, we could demonstrate the full potential of Canon latest technologies.
Canon will continue working as a true solutions provider in Cardiology in Central and South America.
Canon will continue working as a true solutions provider in Cardiology in Central and South America.
The content reflects information available at the time of publication and may differ from current information.
Magazine for Interventional X-ray
Read testimonials from users of Canon' vascular systems.
Due to medical device regulatory reasons, not all products/service displayed on this webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Group representative for further details.
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
